ID

29954

Beschreibung

A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00770861

Link

https://clinicaltrials.gov/show/NCT00770861

Stichworte

  1. 29.04.18 29.04.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

29. April 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hypertension NCT00770861

Eligibility Hypertension NCT00770861

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female outpatients 18 to 80 years of age, self-identified as hispanic or latino ethnicity
Beschreibung

Outpatients | Age | Hispanics | Latinos

Datentyp

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0086409
UMLS CUI [4]
C0086528
females must be post-menopausal, or not pregnant and using an approved contraceptive regimen
Beschreibung

Postmenopausal state | Gender Pregnancy Absent | Gender Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0032961
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0700589
meet criteria for stage i or ii hypertension
Beschreibung

Hypertensive disease Stage

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0699749
currently not treated, or being treated with no more than two anti-hypertensive medications
Beschreibung

Therapeutic procedure Absent | Antihypertensive Agents Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0003364
UMLS CUI [2,2]
C1265611
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
secondary hypertension
Beschreibung

Secondary hypertension

Datentyp

boolean

Alias
UMLS CUI [1]
C0155616
are taking three or more antihypertensive agents
Beschreibung

Antihypertensive Agents Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1265611
have uncontrolled or poorly controlled diabetes mellitus type i or type ii
Beschreibung

DIABETES MELLITUS INSULIN DEPENDENT UNCONTROLLED | DIABETES MELLITUS NON INSULIN DEPENDENT UNCONTROLLED | Insulin-Dependent Diabetes Mellitus Poorly controlled | Non-Insulin-Dependent Diabetes Mellitus Poorly controlled

Datentyp

boolean

Alias
UMLS CUI [1]
C0743113
UMLS CUI [2]
C0743118
UMLS CUI [3,1]
C0011854
UMLS CUI [3,2]
C3853134
UMLS CUI [4,1]
C0011860
UMLS CUI [4,2]
C3853134
evidence of other concurrent disease or conditions that might interfere with the conduct of the study
Beschreibung

Comorbidity Interferes with Clinical Trial | Condition Interferes with Clinical Trial

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0008976
participation in any investigational study within 30 days of screening (visit 1).
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
have a history of hypersensitivity to nebivolol or other β-blockers, or any contraindication to β-blocker use
Beschreibung

Hypersensitivity Nebivolol | BETA BLOCKER ALLERGY | Medical contraindication Adrenergic beta-1 Receptor Antagonists

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0068475
UMLS CUI [2]
C0741466
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0304516

Ähnliche Modelle

Eligibility Hypertension NCT00770861

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Outpatients | Age | Hispanics | Latinos
Item
male and female outpatients 18 to 80 years of age, self-identified as hispanic or latino ethnicity
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0086409 (UMLS CUI [3])
C0086528 (UMLS CUI [4])
Postmenopausal state | Gender Pregnancy Absent | Gender Contraceptive methods
Item
females must be post-menopausal, or not pregnant and using an approved contraceptive regimen
boolean
C0232970 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
Hypertensive disease Stage
Item
meet criteria for stage i or ii hypertension
boolean
C0020538 (UMLS CUI [1,1])
C0699749 (UMLS CUI [1,2])
Therapeutic procedure Absent | Antihypertensive Agents Quantity
Item
currently not treated, or being treated with no more than two anti-hypertensive medications
boolean
C0087111 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0003364 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Secondary hypertension
Item
secondary hypertension
boolean
C0155616 (UMLS CUI [1])
Antihypertensive Agents Quantity
Item
are taking three or more antihypertensive agents
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
DIABETES MELLITUS INSULIN DEPENDENT UNCONTROLLED | DIABETES MELLITUS NON INSULIN DEPENDENT UNCONTROLLED | Insulin-Dependent Diabetes Mellitus Poorly controlled | Non-Insulin-Dependent Diabetes Mellitus Poorly controlled
Item
have uncontrolled or poorly controlled diabetes mellitus type i or type ii
boolean
C0743113 (UMLS CUI [1])
C0743118 (UMLS CUI [2])
C0011854 (UMLS CUI [3,1])
C3853134 (UMLS CUI [3,2])
C0011860 (UMLS CUI [4,1])
C3853134 (UMLS CUI [4,2])
Comorbidity Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Item
evidence of other concurrent disease or conditions that might interfere with the conduct of the study
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Study Subject Participation Status
Item
participation in any investigational study within 30 days of screening (visit 1).
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Nebivolol | BETA BLOCKER ALLERGY | Medical contraindication Adrenergic beta-1 Receptor Antagonists
Item
have a history of hypersensitivity to nebivolol or other β-blockers, or any contraindication to β-blocker use
boolean
C0020517 (UMLS CUI [1,1])
C0068475 (UMLS CUI [1,2])
C0741466 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C0304516 (UMLS CUI [3,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video